These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 30885680)

  • 1. Prototyping kinase inhibitor-cytotoxin anticancer mutual prodrugs activated by tumour hypoxia: A chemical proof of concept study.
    Sansom GN; Kirk NS; Guise CP; Anderson RF; Smaill JB; Patterson AV; Kelso MJ
    Bioorg Med Chem Lett; 2019 May; 29(10):1215-1219. PubMed ID: 30885680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and biological investigations of hypoxia-sensitive prodrugs of the tyrosine kinase inhibitor crizotinib.
    Bielec B; Schueffl H; Terenzi A; Berger W; Heffeter P; Keppler BK; Kowol CR
    Bioorg Chem; 2020 Jun; 99():103778. PubMed ID: 32229347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational modification of semaxanib and sunitinib for developing a tumor growth inhibitor targeting ATP binding site of tyrosine kinase.
    Kaur J; Kaur B; Singh P
    Bioorg Med Chem Lett; 2018 Jan; 28(2):129-133. PubMed ID: 29208523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and evaluation of targeted hypoxia-activated prodrugs applied to chondrosarcoma chemotherapy.
    Gerard Y; Voissière A; Peyrode C; Galmier MJ; Maubert E; Ghedira D; Tarrit S; Gaumet V; Canitrot D; Miot-Noirault E; Chezal JM; Weber V
    Bioorg Chem; 2020 May; 98():103747. PubMed ID: 32208207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, bioconversion, pharmacokinetic and pharmacodynamic evaluation of N-isopropyl-oxy-carbonyloxymethyl prodrugs of CZh-226, a potent and selective PAK4 inhibitor.
    Guo J; Wang T; Wu T; Zhang K; Yin W; Zhu M; Pang Y; Hao C; He Z; Cheng M; Liu Y; Zheng J; Gu J; Zhao D
    Eur J Med Chem; 2020 Jan; 186():111878. PubMed ID: 31757524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia-Activated Prodrugs of PERK Inhibitors.
    Liew LP; Singleton DC; Wong WW; Cheng GJ; Jamieson SMF; Hay MP
    Chem Asian J; 2019 Apr; 14(8):1238-1248. PubMed ID: 30615821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent inhibitors of phosphatidylinositol 3 (PI3) kinase that have antiproliferative activity only when delivered as prodrug forms.
    O'Brien NJ; Amran S; Medan J; Cleary B; Deady LW; Jennings IG; Thompson PE; Abbott BM
    ChemMedChem; 2013 Jun; 8(6):914-8. PubMed ID: 23568455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and one-electron reduction characteristics of radiation-activated prodrugs possessing two 5-fluorodeoxyuridine units.
    Tanabe K; Sugiura M; Ito T; Nishimoto S
    Bioorg Med Chem; 2012 Sep; 20(17):5164-8. PubMed ID: 22847019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, Synthesis and In-Vitro Biological Evaluation of Antofine and Tylophorine Prodrugs as Hypoxia-Targeted Anticancer Agents.
    Omran Z; Guise CP; Chen L; Rauch C; Abdalla AN; Abdullah O; Sindi IA; Fischer PM; Smaill JB; Patterson AV; Liu Y; Wang Q
    Molecules; 2021 Jun; 26(11):. PubMed ID: 34206005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symbiotic prodrugs (SymProDs) dual targeting of NFkappaB and CDK.
    Rana S; Kour S; Sonawane YA; Robb CM; Contreras JI; Kizhake S; Zahid M; Karpf AR; Natarajan A
    Chem Biol Drug Des; 2020 Aug; 96(2):773-784. PubMed ID: 32237047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photoinduced Isomerization and Hepatoxicities of Semaxanib, Sunitinib and Related 3-Substituted Indolin-2-ones.
    Ngai MH; So CL; Sullivan MB; Ho HK; Chai CL
    ChemMedChem; 2016 Jan; 11(1):72-80. PubMed ID: 26593399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and Bioevaluation of Quaternary Centered 3-hydroxy-3 (alkynyl)indolin-2-one Derivatives as Potential Cytotoxic Agents and Akt Kinase Inhibitors.
    Prathima PS; Bikshapathi R; Poornachandra Y; Himabindu V; Kumar GJ; Jagadeesh N; Kumar CG; Rao VJ
    Anticancer Agents Med Chem; 2018 Feb; 17(14):1963-1970. PubMed ID: 28403775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological activity of N-2,3-dihydroxypropyl-N-4-chlorobutyl nucleoside phosphoramidate prodrugs.
    Wu W; Borch RF
    Mol Pharm; 2006; 3(4):451-6. PubMed ID: 16889439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of prodrugs for anti-angiogenic pyrrolylmethylidenyl oxindoles.
    Maskell L; Blanche EA; Colucci MA; Whatmore JL; Moody CJ
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1575-8. PubMed ID: 17254788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and evaluation of molecularly targeted hypoxia-activated prodrugs.
    O'Connor LJ; Cazares-Körner C; Saha J; Evans CN; Stratford MR; Hammond EM; Conway SJ
    Nat Protoc; 2016 Apr; 11(4):781-94. PubMed ID: 27010756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asymmetric synthesis and biological evaluation of glycosidic prodrugs for a selective cancer therapy.
    Tietze LF; von Hof JM; Krewer B; Müller M; Major F; Schuster HJ; Schuberth I; Alves F
    ChemMedChem; 2008 Dec; 3(12):1946-55. PubMed ID: 19021160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Tumor-Activated Prodrug Strategy Targeting Ferrous Iron Is Effective in Multiple Preclinical Cancer Models.
    Spangler B; Fontaine SD; Shi Y; Sambucetti L; Mattis AN; Hann B; Wells JA; Renslo AR
    J Med Chem; 2016 Dec; 59(24):11161-11170. PubMed ID: 27936709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia activated prodrugs of a 9-aza-anthrapyrazole derivative that has promising anticancer activity.
    El-Dakdouki MH; Adamski N; Foster L; Hacker MP; Erhardt PW
    J Med Chem; 2011 Dec; 54(23):8224-7. PubMed ID: 22011244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticancer activities of emetine prodrugs that are proteolytically activated by the prostate specific antigen (PSA) and evaluation of in vivo toxicity of emetine derivatives.
    Akinboye ES; Rosen MD; Bakare O; Denmeade SR
    Bioorg Med Chem; 2017 Dec; 25(24):6707-6717. PubMed ID: 29153549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and biological evaluation of pyrrolobenzodiazepine-containing hypoxia-activated prodrugs.
    Dragovich PS; Broccatelli F; Chen J; Fan P; Le H; Mao W; Pillow TH; Polson AG; Wai J; Xu Z; Yao H; Zhang D
    Bioorg Med Chem Lett; 2017 Dec; 27(23):5300-5304. PubMed ID: 29079474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.